Halofenate, structurally akin to clofibrate, was evaluated in hypertriglyceridemic patients over 6-week periods in a controlled, double-blind crossover trial. It effectively reduced serum triglycerides by 50%, with minimal impact on serum cholesterol lev
Molecular Weight:
415.79
CAS Number:
[26718-25-2]
Formula:
C19H17ClF3NO4
Target:
Others
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted